Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products

References

1. 1.↵
   U.S. FDA Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics-Chemistry, Manufacturing, and Controls Documentation, May 1999; http://www.fda.gov/downloads/Drugs/Guidances/ucm070551.pdf

   Google Scholar
2. 2.↵
   U.S. FDA Guidance for Industry Nasal and Inhalation Solution Drug Products-Chemistry, Manufacturing, and Controls Documentation, July 2002; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070575.pdf

   Google Scholar
3. 3.↵
   Draft U.S. FDA Guidance for Industry. Metered Dose Inhalers (MDI) and Dry Powder Inhalers (DPI) Drug Products-Chemistry, Manufacturing and Controls Documentation, October 1998; http://www.fda.gov/downloads/Drugs/Guidances/ucm070573.pdf

   Google Scholar
4. 4.↵
   Product Quality Research Institute Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products, September 2006; http://www.pqri.org/pdfs/LE_Recommendations_to_FDA_09-29-06.pdf

   Google Scholar
5. 5.↵
   1. Ball D. J.,
   2. Norwood D. L.,
   3. Stults C. L. M,
   4. Nago L. M.

   Leachables and Extractables Handbook; Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products, Ball D. J., Norwood D. L., Stults C. L. M, Nago L. M., Eds.; John Willey & Sons, Inc.: Hoboken, NJ, 2012.

   Google Scholar
6. 6.↵
   1. Jenke D.

   Compatibility of Pharmaceutical Products and Contact Materials; Safety Considerations Associated with Extractables and Leachables; John Willey & Sons, Inc.: Hoboken, NJ, 2009.

   Google Scholar
7. 7.↵
   <1663> Assessment of Extractables Associated with Pharmaceutical Packaging/Delivery Systems. First Supplement to USP 38–NF 33; United States Pharmacopeial Convention, Inc.: Rockville, MD, August 1, 2015; pp 7166–7180.

   Google Scholar
8. 8.↵
   <1664> Assessment of Drug Product Leachables Associated with Pharmaceutical Packaging/Delivery Systems. First Supplement to USP 38–NF 33; United States Pharmacopeial Convention, Inc.: Rockville, MD, August 1, 2015; pp 7181–7190.

   Google Scholar
9. 9.↵
   1. Jenke D.,
   2. Castner J.,
   3. Egert T.,
   4. Feinberg T.,
   5. Hendricker A.,
   6. Houston C.,
   7. Hunt D. G.,
   8. Lynch M.,
   9. Shaw A.,
   10. Nicholas K.,
   11. Norwood D. L.,
   12. Paskiet D.,
   13. Ruberto M.,
   14. Smith E. J.,
   15. Holcomb F.

   Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products. PDA J. Pharm. Sci. Technol. 2013, 67 (5), 448–511; http://journal.pda.org/content/67/5/448.full.pdf+html

   OpenUrlAbstract/FREE Full TextGoogle Scholar
10. 10.↵
    Study Protocol—Stage 2 “Experimental Protocol for Simulation Study of Blow-Fill-Seal (BFS) PODP Container Closure Systems.” PQRI Parenteral and Ophthalmic Drug Products (DODP) Leachables and Extractables Working Group, September, 2011. Available at http://www.pqri.org/commworking/minutes/pdfs/dptc/podpwg/Addl/StudyProtocolStage

    Google Scholar